U.S. and Canada Embark on Project to Develop a Gene Therapy for Retinal Blindness
The goal of this project is to begin testing a new gene therapy in patients who are losing their vision due to retinal disease, by the end of five years,” said Dr. Tsilflidis, Senior Scientist at the Ottawa Hospital Research Institute and Associate Professor in the Faculty of Medicine at the University of Ottawa. By blocking a process (apoptosis) that causes retinal cell death, thus blindness, the XIAP gene therapy protects the retinal cells. The gene is delivered to the eye using a virus.
If you found this article interesting, you can get updates in your email inbox any time similar articles are posted. The subscription options you will be presented with are based on your interest in this article. Just click here to sign up for a free membership and get started!
GET AUTOMATIC UPDATES
Only the News You Want
Subscribe to Macula.Org news by category, topic or even the name of a disease!
PRINT
Comments
Such promising research
These gene therapies are so promising. Is this related to the stem cell research in the recently posted study, linked below?
http://www.macula.org/fda-approves-stem-cell-trial-eyes
Not sure
I couldn't tell - the link to the original story appears to no longer be available.
Amazing research!
This is really amazing! I hope these folks are successful!
Post new comment